Vitro Biopharma Receives Recognition from BioInformant

Vitro Biopharma Receives Recognition from BioInformant

Coronavirus disease (COVID-19) is an emerging global pandemic that is threatening the viability of healthcare systems worldwide. The virus responsible for the disease is also known as severe acute respiratory syndrome coronavirus 2 and abbreviated as SARS-CoV-2. The...

Vitro Biopharma First Quarter 2020 Financial Results of Operations

Golden, Colorado-March 26, 2020- Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced its 1st quarter ended January 31st, 2020 financial results of operations. Vitro Diagnostics Inc. (“Vitro Biopharma”) is pleased to announce a record 1st comparative...
Investigating Stem Cell Therapy for the Coronavirus COVID-19 Pandemic

Investigating Stem Cell Therapy for the Coronavirus COVID-19 Pandemic

Golden, Colorado—March 17, 2020—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma reports on its therapy for the Coronavirus (COVID-19) pandemic.  Recent umbilical cord stem cell therapies in China to fight the Coronavirus are producing encouraging emergency...